Page results
-
The TB network for north central London aims to reduce the capital’s high number of new cases and making it easier for patients to receive treatment.
-
At your first visit to UCLH your midwife will discuss birth place options with you and recommend a place of birth.
-
Preparations for the festive season are in full swing in the UCLH Charity fundraising team.
-
This booklet explains what you can expect during recovery from your autologous stem cell transplant.
-
This page is for patients having planned neurosurgery.
-
We offer management of kidney stone disease, including in-house lithotripsy, rigid ureteroscopy, flexible ureterorenoscopy and laser disintegration of stones in ureters and kidneys and percutaneous nephrolithotomy.
-
Our andrology unit manages patients with andrological conditions including male sterilisation and infertility service, and other disorders of the penis or male genitalia.
-
The London Sarcoma Service is one of the largest sarcoma services in Europe with an international reputation for providing the highest quality of care to patients with sarcoma.
-
This page gives advice for those wanting to refer patients for nuclear medicine investigations at University College London Hospitals NHS Foundation Trust. Given at the end of this page are appropriate referral guidelines for the tests we perform.
-
University College Hospital is one of only eight centres in London that has a Hyper-acute Stroke Unit or a HASU as they are known.
File results
-
FOI/2024/0133 - Non-Emergency Patient Transport Services (NEPTS)
-
FOI/2024/0134 - Joint infection services for paediatric/ adult patients
-
FOI/2024/0136 - Female Genital Mutilation (FGM) cases from 2014-February 2024
-
FOI/2024/0140 - Operations cancelled due to low levels of staffing 2019-2023
-
FOI/2024/0143 - Individuals arriving at A&E not in an ambulance
-
FOI/2024/0144 - Breast cancer treatment
-
FOI/2024/0148 - Cleaning audit system at Trust
-
FOI/2024/0149 - National Hospital for Neurology and Neurosurgery (NHNN) admissions 2018-2023
-
FOI/2024/0155 - Immunotherapy treatments for lung cancer
-
FOI/2024/0162 - Various technology systems/ services used at Trust